Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017
Objective Subcommittee on Survey of Nuclear Medicine Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years. Methods The subcommittee sent questionnaires, including the...
Gespeichert in:
| Veröffentlicht in: | Annals of nuclear medicine 2019-10, Vol.33 (10), p.725-732 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 732 |
|---|---|
| container_issue | 10 |
| container_start_page | 725 |
| container_title | Annals of nuclear medicine |
| container_volume | 33 |
| creator | Nishiyama, Yoshihiro Kinuya, Seigo Kato, Takashi Kayano, Daiki Sato, Shuhei Tashiro, Manabu Tatsumi, Mitsuaki Hashimoto, Teisuke Baba, Shingo Hirata, Kenji Yoshimura, Mana Yoneyama, Hiroto |
| description | Objective
Subcommittee on Survey of Nuclear Medicine Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years.
Methods
The subcommittee sent questionnaires, including the number and category of examinations as well as the kind and dose of the radiopharmaceuticals during the 30 days of June 2017, to all nuclear medicine institutes. The total numbers for the year 2017 were then estimated.
Results
A total of 1132 institutes responded to the survey, including 351 PET centers. The recovery rate was 90.6%. The number of gamma cameras installed was 1332 in total, with 7.0% decrease in 5 years. Dual-head cameras and hybrid SPECT/CT scanners accounted for 88.2 and 23.6%, respectively. The number of single-photon tracer studies in 2017 was 1.08 million which means a decrease in 5.7% in 5 years and 23.6% in 10 years. All but neurotransmitter system, sentinel lymph node, and liver scintigraphy decreased. Bone scintigraphy was a leading examination (32.3%), followed by myocardial scintigraphy (24.1%) and cerebral perfusion study (18.0%) in order. SPECT studies showed an increase from 47.2% to 63.5%. PET centers have also increased from 295 to 389, as compared to the last survey. The 112 PET centers have installed one or two in-house cyclotrons. PET studies showed 24.5% increase in 5 years, with oncology accounting for 88.9%.
18
F-FDG accounted for 98.2% (630,570 examinations). PET examinations using
11
C-methionine have decreased, with 2440 examinations in 2017. PET examinations using
13
N-NH
3
have been increasing, with 2363 examinations in 2017. The number of PET studies using
11
C-PIB was 904.
131
I-radioiodine targeted therapies showed an increase in 5 years (23.1%), including 4487 patients for thyroid cancer. Out-patient thyroid bed ablation therapy with 1,110 MBq of
131
I accounted for 36.6% of cancer patients. The number of admission rooms increased from 135 to 157 in 5 years. The number of
223
Ra targeted therapies for castration-resistant metastatic prostate cancer was 1194 patients.
Conclusions
Single-photon examinations showed a continuous tendency toward a decline in the survey. In contrast, the number of hybrid SPECT/CT scanner examinations has increased. PET/CT study and radionuclide targeted therapy have steadily increased. |
| doi_str_mv | 10.1007/s12149-019-01382-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2246904823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2299479430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-b98883534216422f4c039d41bf5552d553f08a56a09fdc38956b1e4b1a46f4353</originalsourceid><addsrcrecordid>eNp9kD1PwzAURS0EoqXwBxiQJRaWgL9js6GKT1WwlNlyHKd11SbBTkD997i0gMTAYL3B5973dAA4xegSI5RfRUwwUxnCm0clyfgeGGIpWCYYpftgiBRmWY5lPgBHMS4QIpJLcggGFBMq8lwMwfS5t0tnAly50ltfO9gGYztvHfQ1fDKtqa-hgcG1TehgU8Fu7qDzs3k3h7XpfFN_-NLB2Id3t95ECML5MTiozDK6k90cgde72-n4IZu83D-ObyaZZYJ3WaGklJRTRrBghFTMIqpKhouKc05KzmmFpOHCIFWVlkrFRYEdK7BhomIpOAIX2942NG-9i51e-Wjdcmlq1_RRE8KEQkwSmtDzP-ii6UOdrkuUUixXjKJEkS1lQxNjcJVug1-ZsNYY6Y1zvXWuk3P95VxvrjjbVfdFsvgT-ZacALoFYvqqZy787v6n9hOTSYkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2299479430</pqid></control><display><type>article</type><title>Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Nishiyama, Yoshihiro ; Kinuya, Seigo ; Kato, Takashi ; Kayano, Daiki ; Sato, Shuhei ; Tashiro, Manabu ; Tatsumi, Mitsuaki ; Hashimoto, Teisuke ; Baba, Shingo ; Hirata, Kenji ; Yoshimura, Mana ; Yoneyama, Hiroto</creator><creatorcontrib>Nishiyama, Yoshihiro ; Kinuya, Seigo ; Kato, Takashi ; Kayano, Daiki ; Sato, Shuhei ; Tashiro, Manabu ; Tatsumi, Mitsuaki ; Hashimoto, Teisuke ; Baba, Shingo ; Hirata, Kenji ; Yoshimura, Mana ; Yoneyama, Hiroto</creatorcontrib><description>Objective
Subcommittee on Survey of Nuclear Medicine Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years.
Methods
The subcommittee sent questionnaires, including the number and category of examinations as well as the kind and dose of the radiopharmaceuticals during the 30 days of June 2017, to all nuclear medicine institutes. The total numbers for the year 2017 were then estimated.
Results
A total of 1132 institutes responded to the survey, including 351 PET centers. The recovery rate was 90.6%. The number of gamma cameras installed was 1332 in total, with 7.0% decrease in 5 years. Dual-head cameras and hybrid SPECT/CT scanners accounted for 88.2 and 23.6%, respectively. The number of single-photon tracer studies in 2017 was 1.08 million which means a decrease in 5.7% in 5 years and 23.6% in 10 years. All but neurotransmitter system, sentinel lymph node, and liver scintigraphy decreased. Bone scintigraphy was a leading examination (32.3%), followed by myocardial scintigraphy (24.1%) and cerebral perfusion study (18.0%) in order. SPECT studies showed an increase from 47.2% to 63.5%. PET centers have also increased from 295 to 389, as compared to the last survey. The 112 PET centers have installed one or two in-house cyclotrons. PET studies showed 24.5% increase in 5 years, with oncology accounting for 88.9%.
18
F-FDG accounted for 98.2% (630,570 examinations). PET examinations using
11
C-methionine have decreased, with 2440 examinations in 2017. PET examinations using
13
N-NH
3
have been increasing, with 2363 examinations in 2017. The number of PET studies using
11
C-PIB was 904.
131
I-radioiodine targeted therapies showed an increase in 5 years (23.1%), including 4487 patients for thyroid cancer. Out-patient thyroid bed ablation therapy with 1,110 MBq of
131
I accounted for 36.6% of cancer patients. The number of admission rooms increased from 135 to 157 in 5 years. The number of
223
Ra targeted therapies for castration-resistant metastatic prostate cancer was 1194 patients.
Conclusions
Single-photon examinations showed a continuous tendency toward a decline in the survey. In contrast, the number of hybrid SPECT/CT scanner examinations has increased. PET/CT study and radionuclide targeted therapy have steadily increased.</description><identifier>ISSN: 0914-7187</identifier><identifier>EISSN: 1864-6433</identifier><identifier>DOI: 10.1007/s12149-019-01382-5</identifier><identifier>PMID: 31236776</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Ablation ; Ammonia ; Cameras ; Cancer ; Castration ; Computed tomography ; Cyclotrons ; Imaging ; Iodine 131 ; Iodine radioisotopes ; Japan ; Lymph nodes ; Medicine ; Medicine & Public Health ; Metastases ; Methionine ; Neurotransmitters ; Nuclear Medicine ; Nuclear Medicine - statistics & numerical data ; Nuclear Medicine - trends ; Oncology ; Original Article ; Perfusion ; Photons ; Polls & surveys ; Positron emission tomography ; Prostate cancer ; Radioisotopes ; Radiology ; Research Report ; Scanners ; Scintigraphy ; Single photon emission computed tomography ; Surveys and Questionnaires ; Therapy ; Thyroid cancer ; Thyroid gland</subject><ispartof>Annals of nuclear medicine, 2019-10, Vol.33 (10), p.725-732</ispartof><rights>The Japanese Society of Nuclear Medicine 2019</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-b98883534216422f4c039d41bf5552d553f08a56a09fdc38956b1e4b1a46f4353</citedby><cites>FETCH-LOGICAL-c465t-b98883534216422f4c039d41bf5552d553f08a56a09fdc38956b1e4b1a46f4353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12149-019-01382-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12149-019-01382-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31236776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nishiyama, Yoshihiro</creatorcontrib><creatorcontrib>Kinuya, Seigo</creatorcontrib><creatorcontrib>Kato, Takashi</creatorcontrib><creatorcontrib>Kayano, Daiki</creatorcontrib><creatorcontrib>Sato, Shuhei</creatorcontrib><creatorcontrib>Tashiro, Manabu</creatorcontrib><creatorcontrib>Tatsumi, Mitsuaki</creatorcontrib><creatorcontrib>Hashimoto, Teisuke</creatorcontrib><creatorcontrib>Baba, Shingo</creatorcontrib><creatorcontrib>Hirata, Kenji</creatorcontrib><creatorcontrib>Yoshimura, Mana</creatorcontrib><creatorcontrib>Yoneyama, Hiroto</creatorcontrib><title>Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017</title><title>Annals of nuclear medicine</title><addtitle>Ann Nucl Med</addtitle><addtitle>Ann Nucl Med</addtitle><description>Objective
Subcommittee on Survey of Nuclear Medicine Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years.
Methods
The subcommittee sent questionnaires, including the number and category of examinations as well as the kind and dose of the radiopharmaceuticals during the 30 days of June 2017, to all nuclear medicine institutes. The total numbers for the year 2017 were then estimated.
Results
A total of 1132 institutes responded to the survey, including 351 PET centers. The recovery rate was 90.6%. The number of gamma cameras installed was 1332 in total, with 7.0% decrease in 5 years. Dual-head cameras and hybrid SPECT/CT scanners accounted for 88.2 and 23.6%, respectively. The number of single-photon tracer studies in 2017 was 1.08 million which means a decrease in 5.7% in 5 years and 23.6% in 10 years. All but neurotransmitter system, sentinel lymph node, and liver scintigraphy decreased. Bone scintigraphy was a leading examination (32.3%), followed by myocardial scintigraphy (24.1%) and cerebral perfusion study (18.0%) in order. SPECT studies showed an increase from 47.2% to 63.5%. PET centers have also increased from 295 to 389, as compared to the last survey. The 112 PET centers have installed one or two in-house cyclotrons. PET studies showed 24.5% increase in 5 years, with oncology accounting for 88.9%.
18
F-FDG accounted for 98.2% (630,570 examinations). PET examinations using
11
C-methionine have decreased, with 2440 examinations in 2017. PET examinations using
13
N-NH
3
have been increasing, with 2363 examinations in 2017. The number of PET studies using
11
C-PIB was 904.
131
I-radioiodine targeted therapies showed an increase in 5 years (23.1%), including 4487 patients for thyroid cancer. Out-patient thyroid bed ablation therapy with 1,110 MBq of
131
I accounted for 36.6% of cancer patients. The number of admission rooms increased from 135 to 157 in 5 years. The number of
223
Ra targeted therapies for castration-resistant metastatic prostate cancer was 1194 patients.
Conclusions
Single-photon examinations showed a continuous tendency toward a decline in the survey. In contrast, the number of hybrid SPECT/CT scanner examinations has increased. PET/CT study and radionuclide targeted therapy have steadily increased.</description><subject>Ablation</subject><subject>Ammonia</subject><subject>Cameras</subject><subject>Cancer</subject><subject>Castration</subject><subject>Computed tomography</subject><subject>Cyclotrons</subject><subject>Imaging</subject><subject>Iodine 131</subject><subject>Iodine radioisotopes</subject><subject>Japan</subject><subject>Lymph nodes</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Methionine</subject><subject>Neurotransmitters</subject><subject>Nuclear Medicine</subject><subject>Nuclear Medicine - statistics & numerical data</subject><subject>Nuclear Medicine - trends</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Perfusion</subject><subject>Photons</subject><subject>Polls & surveys</subject><subject>Positron emission tomography</subject><subject>Prostate cancer</subject><subject>Radioisotopes</subject><subject>Radiology</subject><subject>Research Report</subject><subject>Scanners</subject><subject>Scintigraphy</subject><subject>Single photon emission computed tomography</subject><subject>Surveys and Questionnaires</subject><subject>Therapy</subject><subject>Thyroid cancer</subject><subject>Thyroid gland</subject><issn>0914-7187</issn><issn>1864-6433</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAURS0EoqXwBxiQJRaWgL9js6GKT1WwlNlyHKd11SbBTkD997i0gMTAYL3B5973dAA4xegSI5RfRUwwUxnCm0clyfgeGGIpWCYYpftgiBRmWY5lPgBHMS4QIpJLcggGFBMq8lwMwfS5t0tnAly50ltfO9gGYztvHfQ1fDKtqa-hgcG1TehgU8Fu7qDzs3k3h7XpfFN_-NLB2Id3t95ECML5MTiozDK6k90cgde72-n4IZu83D-ObyaZZYJ3WaGklJRTRrBghFTMIqpKhouKc05KzmmFpOHCIFWVlkrFRYEdK7BhomIpOAIX2942NG-9i51e-Wjdcmlq1_RRE8KEQkwSmtDzP-ii6UOdrkuUUixXjKJEkS1lQxNjcJVug1-ZsNYY6Y1zvXWuk3P95VxvrjjbVfdFsvgT-ZacALoFYvqqZy787v6n9hOTSYkw</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Nishiyama, Yoshihiro</creator><creator>Kinuya, Seigo</creator><creator>Kato, Takashi</creator><creator>Kayano, Daiki</creator><creator>Sato, Shuhei</creator><creator>Tashiro, Manabu</creator><creator>Tatsumi, Mitsuaki</creator><creator>Hashimoto, Teisuke</creator><creator>Baba, Shingo</creator><creator>Hirata, Kenji</creator><creator>Yoshimura, Mana</creator><creator>Yoneyama, Hiroto</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20191001</creationdate><title>Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017</title><author>Nishiyama, Yoshihiro ; Kinuya, Seigo ; Kato, Takashi ; Kayano, Daiki ; Sato, Shuhei ; Tashiro, Manabu ; Tatsumi, Mitsuaki ; Hashimoto, Teisuke ; Baba, Shingo ; Hirata, Kenji ; Yoshimura, Mana ; Yoneyama, Hiroto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-b98883534216422f4c039d41bf5552d553f08a56a09fdc38956b1e4b1a46f4353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Ablation</topic><topic>Ammonia</topic><topic>Cameras</topic><topic>Cancer</topic><topic>Castration</topic><topic>Computed tomography</topic><topic>Cyclotrons</topic><topic>Imaging</topic><topic>Iodine 131</topic><topic>Iodine radioisotopes</topic><topic>Japan</topic><topic>Lymph nodes</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Methionine</topic><topic>Neurotransmitters</topic><topic>Nuclear Medicine</topic><topic>Nuclear Medicine - statistics & numerical data</topic><topic>Nuclear Medicine - trends</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Perfusion</topic><topic>Photons</topic><topic>Polls & surveys</topic><topic>Positron emission tomography</topic><topic>Prostate cancer</topic><topic>Radioisotopes</topic><topic>Radiology</topic><topic>Research Report</topic><topic>Scanners</topic><topic>Scintigraphy</topic><topic>Single photon emission computed tomography</topic><topic>Surveys and Questionnaires</topic><topic>Therapy</topic><topic>Thyroid cancer</topic><topic>Thyroid gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishiyama, Yoshihiro</creatorcontrib><creatorcontrib>Kinuya, Seigo</creatorcontrib><creatorcontrib>Kato, Takashi</creatorcontrib><creatorcontrib>Kayano, Daiki</creatorcontrib><creatorcontrib>Sato, Shuhei</creatorcontrib><creatorcontrib>Tashiro, Manabu</creatorcontrib><creatorcontrib>Tatsumi, Mitsuaki</creatorcontrib><creatorcontrib>Hashimoto, Teisuke</creatorcontrib><creatorcontrib>Baba, Shingo</creatorcontrib><creatorcontrib>Hirata, Kenji</creatorcontrib><creatorcontrib>Yoshimura, Mana</creatorcontrib><creatorcontrib>Yoneyama, Hiroto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishiyama, Yoshihiro</au><au>Kinuya, Seigo</au><au>Kato, Takashi</au><au>Kayano, Daiki</au><au>Sato, Shuhei</au><au>Tashiro, Manabu</au><au>Tatsumi, Mitsuaki</au><au>Hashimoto, Teisuke</au><au>Baba, Shingo</au><au>Hirata, Kenji</au><au>Yoshimura, Mana</au><au>Yoneyama, Hiroto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017</atitle><jtitle>Annals of nuclear medicine</jtitle><stitle>Ann Nucl Med</stitle><addtitle>Ann Nucl Med</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>33</volume><issue>10</issue><spage>725</spage><epage>732</epage><pages>725-732</pages><issn>0914-7187</issn><eissn>1864-6433</eissn><abstract>Objective
Subcommittee on Survey of Nuclear Medicine Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years.
Methods
The subcommittee sent questionnaires, including the number and category of examinations as well as the kind and dose of the radiopharmaceuticals during the 30 days of June 2017, to all nuclear medicine institutes. The total numbers for the year 2017 were then estimated.
Results
A total of 1132 institutes responded to the survey, including 351 PET centers. The recovery rate was 90.6%. The number of gamma cameras installed was 1332 in total, with 7.0% decrease in 5 years. Dual-head cameras and hybrid SPECT/CT scanners accounted for 88.2 and 23.6%, respectively. The number of single-photon tracer studies in 2017 was 1.08 million which means a decrease in 5.7% in 5 years and 23.6% in 10 years. All but neurotransmitter system, sentinel lymph node, and liver scintigraphy decreased. Bone scintigraphy was a leading examination (32.3%), followed by myocardial scintigraphy (24.1%) and cerebral perfusion study (18.0%) in order. SPECT studies showed an increase from 47.2% to 63.5%. PET centers have also increased from 295 to 389, as compared to the last survey. The 112 PET centers have installed one or two in-house cyclotrons. PET studies showed 24.5% increase in 5 years, with oncology accounting for 88.9%.
18
F-FDG accounted for 98.2% (630,570 examinations). PET examinations using
11
C-methionine have decreased, with 2440 examinations in 2017. PET examinations using
13
N-NH
3
have been increasing, with 2363 examinations in 2017. The number of PET studies using
11
C-PIB was 904.
131
I-radioiodine targeted therapies showed an increase in 5 years (23.1%), including 4487 patients for thyroid cancer. Out-patient thyroid bed ablation therapy with 1,110 MBq of
131
I accounted for 36.6% of cancer patients. The number of admission rooms increased from 135 to 157 in 5 years. The number of
223
Ra targeted therapies for castration-resistant metastatic prostate cancer was 1194 patients.
Conclusions
Single-photon examinations showed a continuous tendency toward a decline in the survey. In contrast, the number of hybrid SPECT/CT scanner examinations has increased. PET/CT study and radionuclide targeted therapy have steadily increased.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>31236776</pmid><doi>10.1007/s12149-019-01382-5</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0914-7187 |
| ispartof | Annals of nuclear medicine, 2019-10, Vol.33 (10), p.725-732 |
| issn | 0914-7187 1864-6433 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2246904823 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Ablation Ammonia Cameras Cancer Castration Computed tomography Cyclotrons Imaging Iodine 131 Iodine radioisotopes Japan Lymph nodes Medicine Medicine & Public Health Metastases Methionine Neurotransmitters Nuclear Medicine Nuclear Medicine - statistics & numerical data Nuclear Medicine - trends Oncology Original Article Perfusion Photons Polls & surveys Positron emission tomography Prostate cancer Radioisotopes Radiology Research Report Scanners Scintigraphy Single photon emission computed tomography Surveys and Questionnaires Therapy Thyroid cancer Thyroid gland |
| title | Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A48%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nuclear%20medicine%20practice%20in%20Japan:%20a%20report%20of%20the%20eighth%20nationwide%20survey%20in%202017&rft.jtitle=Annals%20of%20nuclear%20medicine&rft.au=Nishiyama,%20Yoshihiro&rft.date=2019-10-01&rft.volume=33&rft.issue=10&rft.spage=725&rft.epage=732&rft.pages=725-732&rft.issn=0914-7187&rft.eissn=1864-6433&rft_id=info:doi/10.1007/s12149-019-01382-5&rft_dat=%3Cproquest_cross%3E2299479430%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2299479430&rft_id=info:pmid/31236776&rfr_iscdi=true |